Literature DB >> 8467357

The regulation of aortic endothelial cells by purines and pyrimidines involves co-existing P2y-purinoceptors and nucleotide receptors linked to phospholipase C.

G F Wilkinson1, J R Purkiss, M R Boarder.   

Abstract

1. We have examined the phospholipase C responses in bovine aortic endothelial cells to purines (ATP, ADP and analogues) and the pyrimidine, uridine triphosphate (UTP). 2. The cells responded to purines in a manner consistent with the presence of P2y purinoceptors; both 2-methylthioadenosine 5'-triphosphate (2MeSATP) and adenosine 5'-0-(2-thiodiphosphate) (ADP beta S) were potent agonists (EC50 0.41 microM and 0.85 microM respectively) while beta, gamma-methylene ATP at 300 microM was not. 3. The cells also responded to UTP. The maximal response to UTP was less than that for either 2MeSATP and ADP beta S while adenosine 5'-0-(3-thiotriphosphate) (ATP gamma S) gave the largest maximal response. 4. The concentration-effect curve to UTP was additive in the presence of either 2MeSATP or ADP beta S. However, the concentration-effect curves to ATP gamma S reached the same maximum in the presence or absence of UTP. 5. Suramin, at concentrations between 10 microM and 100 microM was a competitive antagonist for the response to ADP beta S and 2MeSATP but not the response to UTP. 6. The results show that there are two separate, co-existing, receptor populations: P2y-purinoceptors (responding to purines) and nucleotide receptors (responding to both purines and pyrimidines). We conclude that purines such as ATP/ADP may regulate aortic endothelial cells by interacting with two phospholipase C-linked receptors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8467357      PMCID: PMC1908023          DOI: 10.1111/j.1476-5381.1993.tb12862.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  23 in total

Review 1.  Is there a basis for distinguishing two types of P2-purinoceptor?

Authors:  G Burnstock; C Kennedy
Journal:  Gen Pharmacol       Date:  1985

Review 2.  Extracellular ATP: effects, sources and fate.

Authors:  J L Gordon
Journal:  Biochem J       Date:  1986-01-15       Impact factor: 3.857

3.  Stimulation of prostacyclin release from aortic smooth muscle cells by purine and pyrimidine nucleotides.

Authors:  D Demolle; C Lagneau; J M Boeynaems
Journal:  Eur J Pharmacol       Date:  1988-10-18       Impact factor: 4.432

4.  Culture of arterial endothelial cells: characterization and growth of bovine aortic cells.

Authors:  F M Booyse; B J Sedlak; M E Rafelson
Journal:  Thromb Diath Haemorrh       Date:  1975-12-15

5.  Extracellular nucleotides stimulate receptor-mediated calcium mobilization and inositol phosphate production in human fibroblasts.

Authors:  J Fine; P Cole; J S Davidson
Journal:  Biochem J       Date:  1989-10-15       Impact factor: 3.857

6.  P2-purinergic agonists stimulate phosphodiesteratic cleavage of phosphatidylcholine in endothelial cells. Evidence for activation of phospholipase D.

Authors:  T W Martin; K Michaelis
Journal:  J Biol Chem       Date:  1989-05-25       Impact factor: 5.157

7.  Involvement of inositol 1,4,5-trisphosphate and calcium in the action of adenine nucleotides on aortic endothelial cells.

Authors:  S Pirotton; E Raspe; D Demolle; C Erneux; J M Boeynaems
Journal:  J Biol Chem       Date:  1987-12-25       Impact factor: 5.157

8.  Stimulation of phosphatidate synthesis in endothelial cells in response to P2-receptor activation. Evidence for phospholipase C and phospholipase D involvement, phosphatidate and diacylglycerol interconversion and the role of protein kinase C.

Authors:  J R Purkiss; M R Boarder
Journal:  Biochem J       Date:  1992-10-01       Impact factor: 3.857

9.  Different P2-purinergic receptor subtypes of endothelium and smooth muscle in canine blood vessels.

Authors:  D A Houston; G Burnstock; P M Vanhoutte
Journal:  J Pharmacol Exp Ther       Date:  1987-05       Impact factor: 4.030

10.  Regional characterization of agonist and depolarization-induced phosphoinositide hydrolysis in rat brain.

Authors:  T A Rooney; S R Nahorski
Journal:  J Pharmacol Exp Ther       Date:  1986-12       Impact factor: 4.030

View more
  28 in total

1.  Distinct Ca(2+) signalling mechanisms induced by ATP and sphingosylphosphorylcholine in porcine aortic smooth muscle cells.

Authors:  T Y Chin; S H Chueh
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

2.  Evaluation of P2-purinoceptor antagonists at two relaxation-mediating P2-purinoceptors in guinea-pig taenia coli.

Authors:  R Bültmann; O Dudeck; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-03       Impact factor: 3.000

3.  Co-existence of P2Y-and PPADS-insensitive P2U-purinoceptors in endothelial cells from adrenal medulla.

Authors:  J Mateo; M T Miras-Portugal; E Castro
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

Review 4.  P2 receptor subtypes in the cardiovascular system.

Authors:  S P Kunapuli; J L Daniel
Journal:  Biochem J       Date:  1998-12-15       Impact factor: 3.857

5.  Responses of the longitudinal muscle and the muscularis mucosae of the rat duodenum to adenine and uracil nucleotides.

Authors:  C R Johnson; S J Charlton; S M Hourani
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

6.  A novel P2-purinoceptor expressed by a subpopulation of astrocytes from the dorsal spinal cord of the rat.

Authors:  C Ho; J Hicks; M W Salter
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

Review 7.  New insights on P2X purinoceptors.

Authors:  P P Humphrey; G Buell; I Kennedy; B S Khakh; A D Michel; A Surprenant; D J Trezise
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-12       Impact factor: 3.000

8.  Characterisation of P2Y2 receptors in human vascular endothelial cells using AR-C118925XX, a competitive and selective P2Y2 antagonist.

Authors:  Markie O Muoboghare; Robert M Drummond; Charles Kennedy
Journal:  Br J Pharmacol       Date:  2019-07-06       Impact factor: 8.739

9.  Effects of pyrimidines on the guinea-pig coronary vasculature.

Authors:  A J Vials; G Burnstock
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

10.  Stimulation of phospholipase C in cultured microvascular endothelial cells from human frontal lobe by histamine, endothelin and purinoceptor agonists.

Authors:  J R Purkiss; D West; L C Wilkes; C Scott; P Yarrow; G F Wilkinson; M R Boarder
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.